Efficacy and Safety of Remdesivir over Two Waves of the SARS-CoV-2 Pandemic
The aim of this study is to describe the features, the outcomes, and the clinical issues related to Remdesivir administration of a cohort of 220 patients (pts) with COVID-19 hospitalized throughout the last two pandemic waves in Italy. One hundred and nine pts were enrolled from 1 September 2020, to...
Main Authors: | Mariacristina Poliseno, Crescenzio Gallo, Donatella Concetta Cibelli, Graziano Antonio Minafra, Irene Francesca Bottalico, Serena Rita Bruno, Maria Luca D’Errico, Laura Montemurro, Marianna Rizzo, Lucia Barbera, Giacomo Emanuele Custodero, Antonella La Marca, Donatella Lo Muzio, Anna Miucci, Teresa Antonia Santantonio, Sergio Lo Caputo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/12/1477 |
Similar Items
-
Use of Remdesivir in children with COVID-19: report of an Italian multicenter study
by: Lorenza Romani, et al.
Published: (2024-02-01) -
The use of Remdesivir in pregnant women with COVID-19
by: Gulbanu Shaimerdenova, et al.
Published: (2023-02-01) -
Comparative therapeutic efficiency of remdesivir in COVID in a tertiary care center
by: Mahendra Munirathnam, et al.
Published: (2021-01-01) -
Publicaciones sobre hidroxicloroquina y remdesivir: actualización septiembre 2020
by: Flor álvarez de Toledo
Published: (2020-10-01) -
Publicaciones sobre hidroxicloroquina y remdesivir: actualización septiembre 2020
by: Flor álvarez de Toledo
Published: (2020-10-01)